HIGHER EFFICACY AND REDUCED ADVERSE REACTIONS IN NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER BY USING PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH PIRARUBICIN

Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin

Abstract The present study aimed to investigate the efficacy and toxicity of pegylated liposomal doxorubicin (PLD) in preoperative neoadjuvant chemotherapy for patients with breast cancer by comparing with conventional anthracycline.This study is a non-randomized controlled trial.Prospective analysis was conducted after matching as required.A total

read more

Independent lung ventilation with use of a double-lumen endotracheal tube for refractory hypoxemia and shock complicating severe unilateral pneumonia: A case report

Background: The indications for independent lung ventilation (ILV) in critical care settings have not been fully clarified, especially because extracorporeal membrane oxygenation (ECMO) is being used increasingly in cases of severe respiratory failure.Case report: A 90-year-old man presented with severe unilateral pneumonia, and despite conventiona

read more